Mark A Schlossberg - Net Worth and Insider Trading
Mark A Schlossberg Net Worth
The estimated net worth of Mark A Schlossberg is at least $7 Million dollars as of 2024-09-21. Mark A Schlossberg is the SVP - Legal & General Counsel of Cytokinetics Inc and owns about 103,408 shares of Cytokinetics Inc (CYTK) stock worth over $6 Million. Mark A Schlossberg is also the SVP and General Counsel of Impax Laboratories Inc and owns about 73,588 shares of Impax Laboratories Inc (IPXL) stock worth over $1 Million. Details can be seen in Mark A Schlossberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark A Schlossberg has not made any transactions after 2022-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark A Schlossberg
Mark A Schlossberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark A Schlossberg owns 2 companies in total, including Cytokinetics Inc (CYTK) , and EOM Pharmaceutical Holdings Inc (IMUC) .
Click here to see the complete history of Mark A Schlossberg’s form 4 insider trades.
Insider Ownership Summary of Mark A Schlossberg
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CYTK | Cytokinetics Inc | 2022-03-15 | SVP - Legal & General Counsel |
IMUC | EOM Pharmaceutical Holdings Inc | 2016-06-17 | director |
Mark A Schlossberg Latest Holdings Summary
Mark A Schlossberg currently owns a total of 2 stocks. Among these stocks, Mark A Schlossberg owns 103,408 shares of Cytokinetics Inc (CYTK) as of March 15, 2022, with a value of $6 Million and a weighting of 80.51%. Mark A Schlossberg also owns 73,588 shares of Impax Laboratories Inc (IPXL) as of September 11, 2015, with a value of $1 Million and a weighting of 19.49%.
Latest Holdings of Mark A Schlossberg
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CYTK | Cytokinetics Inc | 2022-03-15 | 103,408 | 53.78 | 5,561,282 |
IPXL | Impax Laboratories Inc | 2015-09-11 | 73,588 | 18.30 | 1,346,660 |
Holding Weightings of Mark A Schlossberg
Mark A Schlossberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark A Schlossberg has made a total of 4 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cytokinetics Inc is the sale of 25,196 shares on March 15, 2022, which brought Mark A Schlossberg around $855,656.
According to the SEC Form 4 filings, Mark A Schlossberg has made a total of 0 transactions in Impax Laboratories Inc (IPXL) over the past 5 years. The most-recent trade in Impax Laboratories Inc is the sale of 7,457 shares on September 11, 2015, which brought Mark A Schlossberg around $322,888.
Insider Trading History of Mark A Schlossberg
- 1
Mark A Schlossberg Trading Performance
GuruFocus tracks the stock performance after each of Mark A Schlossberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark A Schlossberg is 12.54%. GuruFocus also compares Mark A Schlossberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark A Schlossberg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark A Schlossberg's insider trading performs compared to the benchmark.
Performance of Mark A Schlossberg
Mark A Schlossberg Ownership Network
Mark A Schlossberg Owned Company Details
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Mark A Schlossberg is the SVP - Legal & General Counsel of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Mark A Schlossberg made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 373,500 shares made by Robert I Blum , a net sale of 183,194 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .
In summary, during the past 3 months, insiders sold 137,437 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 137,437 shares. During the past 18 months, 658,744 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 658,744 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
Mark A Schlossberg Mailing Address
Above is the net worth, insider trading, and ownership report for Mark A Schlossberg. You might contact Mark A Schlossberg via mailing address: C/o Impax Laboratories, Inc., 30831 Huntwood Avenue, Hayward Ca 94544.